Hydroxyurea reduces hyper-adhesion measured by a VLA-4 targeting PET tracer in sickle transgenic Townes mice
Open Access
- 25 March 2026
- journal article
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (19) , 6764-6767
Abstract
Nishi Yadav, Qin Zhu, Lynda L Little-Ihrig, Joseph D Latoche, Kathryn E Day, Kanishka Sikligar, Sina Tavakoli, Enrico M Novelli, Carolyn Anderson; HydroxyuKeywords
This publication has 22 references indexed in Scilit:
- Hydroxyurea Decouples Persistent F-Cell Elevation and Induction of γ-GlobinExperimental Hematology, 2022
- Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan AfricaNew England Journal of Medicine, 2019
- Crises in Sickle Cell DiseaseChest, 2016
- Evaluation of 68Ga- and 177Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic MelanomaMolecular Pharmaceutics, 2015
- Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease miceBlood, 2012
- Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectinBlood, 2012
- Hydroxyurea in sickle cell disease—A study of clinico-pharmacological efficacy in the Indian haplotypeBlood Cells, Molecules, and Diseases, 2009
- Pathophysiology of Stroke in Sickle Cell DiseaseMicrocirculation, 2004
- Nitric oxide donor properties of hydroxyurea in patients with sickle cell diseaseBritish Journal of Haematology, 2002
- Pathogenesis and Treatment of Sickle Cell DiseaseNew England Journal of Medicine, 1997